Viela Bio, Inc. logo
Viela Bio, Inc. VIE

Viela Bio, Inc. Revenue 2011-2026 | VIE

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue Viela Bio, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
11.7 M 50 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
50 M 11.7 M 30.8 M

References

  1. Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Biotechnology industry

Issuer Revenue Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
238 M - 2.43 % $ 254 M germanyGermany
Anika Therapeutics Anika Therapeutics
ANIK
167 M $ 14.93 0.88 % $ 219 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
912 K $ 0.93 0.51 % $ 5.07 M chinaChina
Aquestive Therapeutics Aquestive Therapeutics
AQST
44.5 M $ 4.14 0.36 % $ 443 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
82 M $ 8.39 4.5 % $ 230 M israelIsrael
Ardelyx Ardelyx
ARDX
407 M $ 6.06 1.94 % $ 1.46 B usaUSA
argenx SE argenx SE
ARGX
36.4 M $ 749.68 0.44 % $ 25 B niderlandNiderland
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
376 M $ 23.93 1.27 % $ 3.04 B usaUSA
Arvinas Arvinas
ARVN
263 M $ 11.36 4.7 % $ 805 M usaUSA
I-Mab I-Mab
IMAB
88 M - - $ 866 M chinaChina
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
829 M $ 61.99 1.57 % $ 8.29 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
6.07 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
70.9 M - 2.54 % $ 160 B franceFrance
Assembly Biosciences Assembly Biosciences
ASMB
72.3 M $ 29.09 0.28 % $ 326 M usaUSA
Actinium Pharmaceuticals Actinium Pharmaceuticals
ATNM
90 K $ 1.13 15.26 % $ 35.3 M usaUSA
Atossa Therapeutics Atossa Therapeutics
ATOS
1.76 K $ 5.19 -3.36 % $ 44.7 M usaUSA
Atara Biotherapeutics Atara Biotherapeutics
ATRA
121 M $ 5.0 0.2 % $ 62.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
381 K - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 K - -1.52 % $ 24.7 M usaUSA
Aurinia Pharmaceuticals Aurinia Pharmaceuticals
AUPH
77.1 M $ 16.05 2.79 % $ 2.16 B canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
75.4 M $ 1.41 -0.35 % $ 375 M britainBritain
Acorda Therapeutics Acorda Therapeutics
ACOR
118 M - -24.86 % $ 820 K usaUSA
Axon Enterprise Axon Enterprise
AXON
2.08 B $ 411.97 -0.2 % $ 31.2 B usaUSA
Aytu BioScience Aytu BioScience
AYTU
66.4 M $ 2.65 -1.12 % $ 16.6 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
1 M - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
13 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
9.59 M - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
130 K - -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
123 M - 1.93 % $ 17.4 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
886 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
325 K - - $ 26.5 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
1.08 B - - - russiaRussia
BioCardia BioCardia
BCDA
58 K $ 1.18 -1.67 % $ 7.87 M usaUSA
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
451 M $ 9.59 6.26 % $ 1.98 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
30.1 M - - $ 2.17 B usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
463 M $ 9.46 -3.47 % $ 612 M usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
28.9 M $ 2.32 4.98 % $ 908 M israelIsrael
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
3.22 B $ 56.04 0.96 % $ 10.7 B usaUSA
BioNTech SE BioNTech SE
BNTX
482 M $ 91.64 0.5 % $ 27.2 B germanyGermany
Aravive Aravive
ARAV
9.14 M - -13.39 % $ 1.45 M usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
642 K $ 1.18 -0.42 % $ 14.4 M usaUSA
Burford Capital Limited Burford Capital Limited
BUR
330 M $ 4.5 8.57 % $ 683 M britainBritain